Werewolf Therapeutics, Inc. Profile Avatar - Palmy Investing

Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecule…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Werewolf Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Werewolf Therapeutics, Inc. has no acquisition track records yet.

End of HOWL's Analysis
CIK: 1785530 CUSIP: 95075A107 ISIN: US95075A1079 LEI: - UEI: -
Secondary Listings
HOWL has no secondary listings inside our databases.